By Editor , 13 September 2026

Phoenix – September 12, 2026 -- BridgePort Financial Solutions has named Tina Decker, a former Osaic executive who negotiated more than 400 M&A deals representing over $10 billion in acquired and retained assets, as its new Senior Vice President of Business Development.

By Editor , 13 September 2026
Aitech Launches Rugged AI GPGPU Boards for Defense Edge Computing

Chatsworth, Calif. – September 12, 2026 -- Aitech has unveiled the 3U VPX C530 and SOSA-aligned U-C5300 GPGPU boards, delivering up to 9,728 CUDA cores, 304 Tensor Cores and 76 ray-tracing cores for defense and aerospace platforms. The rugged AI accelerators produce up to 35.8 TFLOPS of FP32 compute performance and 576 GB/s of memory bandwidth, targeting real-time AI inference at the tactical edge.

By Editor , 13 September 2026
Bitmine's ETH Holdings Hit 5.93M Tokens, Total Assets Reach $15.7B

Norwalk, Conn. – September 12, 2026 -- Bitmine Immersion Technologies (NYSE: BMNR) disclosed that its total crypto, cash and marketable securities holdings reached $15.7 billion as of September 7, 2026, driven by an Ethereum treasury of 5,929,198 ETH tokens valued at $2,495 per coin.

The holding equals 4.9% of ETH's total 122.0 million token supply, putting the company 97% of the way toward its stated goal of acquiring 5% of all Ethereum in circulation just 15 months after launching its treasury strategy on June 30, 2025.

By Editor , 13 September 2026

New York – September 12, 2026 -- Cerberus Capital Management has agreed to acquire a substantial part of the Mechanical Engineering Division of Goodwin plc for a headline cash consideration of up to approximately £1.1 billion, subject to customary purchase price adjustments. The deal is expected to close in the first quarter of 2027, pending regulatory approvals and other customary closing conditions.

By Editor , 13 September 2026
EpilepsyGTx Taps Viralgen to Scale AAV Gene Therapy EPY201

London and San Sebastián, Spain – September 12, 2026 -- EpilepsyGTx has partnered with AAV-focused CDMO Viralgen to manufacture EPY201, an investigational gene therapy targeting focal refractory epilepsy (FRE), a condition affecting an estimated 10 million patients worldwide, including 2 million across the US, UK and EU.

By Editor , 13 September 2026
Revizto Academy Hits 13,500 Certifications as Construction Workforce Gap Widens

Lausanne, Switzerland – – September 12, 2026 -- Revizto Academy, the free digital coordination training program run by AECO collaboration platform Revizto, has awarded more than 13,500 certifications to professionals in over 60 countries since its 2024 launch, the company said marking the program's two-year anniversary.

By Editor , 13 September 2026
CD&R Names Ex-BMS CEO Giovanni Caforio Operating Advisor

London – September 9, 2026 -- CD&R has appointed Giovanni Caforio, current Chair of Novartis and former CEO of Bristol Myers Squibb (BMS), as an Operating Advisor to its funds, tasking him with sourcing and evaluating healthcare investment opportunities globally.

By Editor , 13 September 2026
ASE Technology Discloses August 2026 Net Revenue Report

Taipei – September 12, 2026 -- ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711) has released its unaudited consolidated net revenues for August 2026, covering its assembly, testing and material (ATM) business segment.